首页|Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei

Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei

扫码查看
Introduction: The pathologic classification of pseudomyxoma peritonei is controversial. This study aimed to standardize the histopathological evaluation of pseudomyxoma peritonei and identify the clinicopathological factors associated with survival. Methods: A pathologic review was performed to systematize the pathology report and verify the relationship between clinical features and survival. Terminology was based on the World Health Organization and Peritoneal Surface Oncology Group International definitions. Preoperative serum levels of carcinoembryonic antigen, CA19-9, and CA-125 were evaluated to determine their association with overall survival (OS) and ability to predict CC0-1 cytoreduction. Results: Among 109 patients with carcinomas resulting from primary appendiceal neoplasms, 72 had pseudomyxoma peritonei of appendiceal origin and underwent debulking surgery. CC0-1 cytoreduction and CC2-3 cytoreduction were achieved in 61% and 39% of patients, respectively. Patients in the CC0-1 and CC2-3 groups had an OS of 122.80 and 32.92 mo, respectively. The histologic grade was associated with CC0-1 cytoreduction; however, it did not influence OS. Patients with CC0-1 cytoreduction, acellular mucin, and low-grade lesions had better disease-free survival. Higher preoperative CA19-9 levels were associated with poor OS. Normal carcinoembryonic antigen values were associated with 100% sensitivity for predicting CC0-1. CA19-9 levels of 625 U/mL were associated with a low possibility of predicting CC0-1. Conclusions: Histologic grades are associated with disease-free survival when CC0-1 cytoreduction is achieved. Normal preoperative CA19-9 levels were associated with a better OS. CC0-1 cytoreduction is the main determinant of longer survival. (c) 2022 Elsevier Inc. All rights reserved.

Pseudomyxoma peritoneiCarcinoembryonic antigenCA-19-9 antigenCA-125 antigenCytoreductive surgeryHYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPYAPPENDICEAL MUCINOUS NEOPLASMSSURVIVALSURGERYCARCINOMATOSISCLASSIFICATIONMANAGEMENTCA-19-9CEA

Lopes, Andre、de Mello, Evandro Sobroza、Mendoza Lopez, Rossana Veronica、Leonardi, Paulo Cesar、Ribeiro Jr, Ulysses

展开 >

Fac Med,Univ Sao Paulo

2022

The Journal of surgical research.

The Journal of surgical research.

ISSN:0022-4804
年,卷(期):2022.274
  • 1
  • 28